Stato
n.d.
ne disponebla
Kunhavigi
Financaj datumoj (2020-01-31)
Kvanto financita
EUR
766 042,00
Minimuma objektivo
EUR
500 000,00
Detaloj
Lando
Finnlando
Sektoro
SanzorgoBiotechnology
Finfina dato
2020-01-31
(2398 tagoj)
Priskribo
“Askel offers a unique way to rebuild joint surfaces for pain-free movement. COPLA® is a medical device already on the 250M€ market for animal health with excellent clinical results. The next step is to enter into the 2.2B$ human market.”